神经基因公司 NGNE
$25.31 −$0.34 (-1.33%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $25.31 0.00%
开盘$26.33
昨收$25.65
当日区间$24.68 – $27.26
成交量324.9K
市值$506.49M
市盈率（TTM）–
股息率–
股权结构与仓位
谁在持有、谁在做空，以及大资金的流向
机构持股比例97.5%-15.72 个百分点，较上季度
持仓机构数150+7 ，较上季度
内部人近期交易37次买入 / 11次卖出净买入
空头持仓比例25.45% 占流通股回补天数 14.4 · 截至 15 Oct 2026
卖空成交量占比25.0%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入，近20个交易日
大单买入减卖出的净额（美元）。该窗口期内：−$1.03M（4个净流入日，16个净流出日）。
按单量净流入，近20个交易日
超大单/大单近似机构级别交易；中单/小单近似散户级别交易。各档买入减卖出净额，按窗口期累计。
已披露的前五大股东合计持有41.3%的流通股。
最大股东
按投资者类型
过去6次双周报告中（31 Jul 2026至15 Oct 2026），空头持仓占流通股比例已从15.57%升至25.45%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Jennison Associates LLC | Mutual Fund | 2026/Q3 | +1,710,500 | 11.1% |
| Rachel McMinn | Individual/Insider | 2026/Q3 | +26,656 | 6.6% |
| Man Investment Partners (US) LP | Mutual Fund | 2026/Q3 | +24,669 | 0.1% |
| Nuveen Asset Management LLC | Insurance Company | 2026/Q3 | +23,857 | 0.1% |
| Franklin Resources | Mutual Fund | 2026/Q3 | +204,234 | 1.0% |
| Point72 Asset Management, L.P. | Hedge Fund | 2026/Q3 | +141,920 | 0.7% |
| Moore Capital Management, LP | Hedge Fund | 2026/Q3 | +141,636 | 0.7% |
| Casdin Capital, LLC | VC/PE Fund | 2026/Q3 | +125,000 | 7.7% |
| Driehaus Capital Management LLC | Mutual Fund | 2026/Q3 | +110,763 | 0.7% |
| Balyasny Asset Management L.P. | Hedge Fund | 2026/Q3 | +100,317 | 4.1% |
| Trexquant Investment LP | Hedge Fund | 2026/Q3 | +73,762 | 0.4% |
| BlackRock | Mutual Fund | 2026/Q3 | +52,913 | 5.3% |
| Dafna Capital Management, LLC | Hedge Fund | 2026/Q3 | +32,397 | 0.4% |
| Wellington Management Group | Mutual Fund | 2026/Q3 | +31,393 | 0.2% |
| Vanguard Portfolio Management, LLC | Mutual Fund | 2026/Q3 | +30,521 | 0.5% |
按报告期列出的机构买卖动态，变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 21 Sep 2026 | Rachel McMinn | Founder, Executive Chair & CEO | Derivative Exercise and Retained | +756 | $25.32 | 1,329,130 |
| 6 Jul 2026 | Christine Cvijic | Chief Financial Officer | Automatic Disposition | -4,800 | $36.13 | 37,872 |
| 1 Jul 2026 | Christine Cvijic | Chief Financial Officer | Automatic Disposition | -4,800 | $35.23 | 42,672 |
| 5 May 2026 | Christine Cvijic | Chief Financial Officer | Automatic Disposition | -9,600 | $32.44 | 47,472 |
| 4 May 2026 | Christina Shafer | Chief Commercial Officer | Other Derivative Acquisition | +120,000 | $28.94 | 120,000 |
| 25 Mar 2026 | Rachel McMinn | Founder, Executive Chair & CEO | Open Market Disposition | -3,352 | $22.07 | 1,302,474 |
| 25 Mar 2026 | Christine Cvijic | Chief Financial Officer | Open Market Disposition | -2,558 | $21.62 | 57,072 |
| 25 Mar 2026 | Julie Jordan | Chief Medical Officer | Open Market Disposition | -828 | $21.89 | 3,605 |
| 12 Mar 2026 | Christine Cvijic | Chief Financial Officer | Open Market Disposition | -4,045 | $22.02 | 52,863 |
| 12 Mar 2026 | Stuart Cobb | Chief Scientific Officer | Automatic Disposition | -6,797 | $22.08 | – |
| 26 Feb 2026 | Christine Cvijic | Chief Financial Officer | Automatic Disposition | -4,800 | $25.11 | 46,274 |
| 19 Feb 2026 | Robert Baffi | Independent Director | Other Derivative Acquisition | +12,050 | $17.64 | 12,050 |
| 19 Feb 2026 | Rohan Palekar | Independent Director | Other Derivative Acquisition | +12,050 | $17.64 | 12,050 |
| 19 Feb 2026 | Rachel McMinn | Founder, Executive Chair & CEO | Other Acquisition | +25,900 | – | 49,800 |
| 19 Feb 2026 | Rachel McMinn | Founder, Executive Chair & CEO | Other Derivative Acquisition | +155,100 | $17.64 | 155,100 |
| 19 Feb 2026 | Sarah Noonberg | Independent Director | Other Derivative Acquisition | +12,050 | $17.64 | 12,050 |
| 19 Feb 2026 | Christine Cvijic | Chief Financial Officer | Other Acquisition | +22,000 | – | 63,569 |
| 19 Feb 2026 | Christine Cvijic | Chief Financial Officer | Other Derivative Acquisition | +131,900 | $17.64 | 131,900 |
| 19 Feb 2026 | Cory Freedland | Lead Independent Director | Other Derivative Acquisition | +12,050 | $17.64 | 12,050 |
| 19 Feb 2026 | Robert Woods | Independent Director | Other Derivative Acquisition | +12,050 | $17.64 | 12,050 |
数据来自Form 4/Form 144申报文件。负数为减持（出售、赠予或代扣税款股份），正数为增持。
空头持仓（按报告期）
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 5,093,623 | 25.5% | 14.4 |
| 30 Sep 2026 | 4,974,749 | 24.9% | 11.7 |
| 15 Sep 2026 | 3,280,172 | 16.4% | 16.9 |
| 31 Aug 2026 | 3,135,369 | 15.7% | 13.6 |
| 14 Aug 2026 | 3,038,441 | 15.2% | 16.8 |
| 31 Jul 2026 | 3,005,232 | 15.6% | 16.2 |
暂无评论——快来第一个聊聊 NGNE。
登录后参与讨论。